摘要
急性肺栓塞发病率高,症状的不典型性容易引起误诊。诊断和危险分层决定了急性肺栓塞的治疗策略。抗凝和系统性溶栓是几十年来的主要的治疗选择,腔内介入技术越来越多地应用于急性肺栓塞的治疗中。尤其对于存在出血风险的病人,可能可以达到降低病人的总体风险,改善预后的作用。仍需要大规模高质量研究数据提供更多临床证据完善相关诊疗方案。
The incidence of acute pulmonary embolism is high,and the atypical symptoms are easy to cause misdiagnosis.Diagnosis and risk stratification determine the treatment strategy for acute pulmonary embolism.Anticoagulation and systemic thrombolysis have been the main treatment options for decades,and endovascular techniques have been increasingly used in the treatment of acute pulmonary embolism.Especially for patients with bleeding risk,it may reduce the overall risk of patients and improve the prognosis.Better protocols and treatment algorithms that are derived from sound,large-scale randomized clinical trials will be crucial.
作者
杨心蕊
叶开创
陆信武
YANG Xin-rui;YE Kai-chuang;LU Xin-wu(Department of Vascular Surgery,Shanghai Ninth People’s Hospital,Shanghai Jiaotong University School of Medicine,Vascular Center of Shanghai Jiaotong University,Shanghai 200011,China)
出处
《中国实用外科杂志》
CSCD
北大核心
2020年第12期1369-1372,共4页
Chinese Journal of Practical Surgery
基金
上海市科学技术委员会医学引导类项目(No.19411966100)
国家自然科学基金项目(No.81700432,No.81870346)
上海交通大学医学院附属第九人民医院临床研究项目(No.JYLJ019)
关键词
急性肺栓塞
危险分层
抗凝
溶栓
腔内治疗
acute pulmonary embolism
risk stratification
anticoagulation
thrombolysis
endovascular treatment
